Today: 11 June 2026
Caterpillar stock today: CAT slips in after-hours as year-end trading thins out
30 December 2025
2 mins read

Caterpillar stock today: CAT slips in after-hours as year-end trading thins out

NEW YORK, December 29, 2025, 19:03 ET — After-hours

  • CAT was last down about 0.7% in after-hours trade after a choppy session.
  • U.S. stocks ended lower as investors rotated out of heavyweight tech names into year-end.
  • A regulatory filing showed CEO Joe Creed received cash-settled phantom stock units under a deferred plan.

Caterpillar Inc (CAT.N) shares were down 0.7% at $578.61 in after-hours trading on Monday. The stock traded between $574.97 and $583.56 during the session, with about 2.6 million shares changing hands.

The heavy-equipment maker is one of the market’s most watched industrial bellwethers, with demand tied to construction, mining and energy projects. That makes its shares a quick barometer for shifts in sentiment on global growth and capital spending.

The timing matters. With just a few sessions left in the year, thinner liquidity can amplify moves in cyclical names, especially when investors rebalance portfolios around big macro calls.

Wall Street’s main indexes ended lower on Monday as investors trimmed exposure to big technology stocks after last week’s run to record highs. Some investors had been hoping for a “Santa Claus rally” — the seasonal stretch where the S&P 500 typically posts gains in the last five trading days of the year and the first two in January — but the market slipped as traders looked ahead to Fed minutes and weekly jobless claims in an otherwise light data week. “It’ll turn out to be a buying opportunity,” said Hank Smith, director and head of investment strategy at Haverford Trust. Reuters

In company-specific news, a filing showed CEO Joseph E. Creed reported receiving 26 phantom stock units tied to Caterpillar stock in a non-qualified deferred compensation plan. Phantom stock units are bookkeeping units that track the value of shares but, in this case, are set to be settled 100% in cash upon retirement or separation, the filing said.

The Form 4 said 13 units were credited at $583 per unit, while 13 were contributed for no consideration under the plan’s terms. Creed reported holding 10,699 phantom stock units after the transaction, according to the filing.

Elsewhere in the industrial complex, shares were mixed in after-hours trade, with Cummins down 0.9% and United Rentals off 1.1%, while Deere edged up about 0.3%.

For Caterpillar, traders will keep one eye on rates and one on the tape. Lower yields can support cyclical valuations, but the stock tends to move with expectations for construction activity and heavy-equipment demand.

Before the next session, investors will track a holiday-week calendar that leaves little room for surprises. U.S. stock and bond markets will be open through Wednesday and closed Thursday for New Year’s Day, with several economic releases — including the Fed’s minutes — set to compete for attention in thin trading.

Caterpillar also has a dividend milestone on the calendar: the company’s dividend schedule lists an ex-dividend date of January 20 for a $1.51 quarterly payout.

The next major company catalyst is expected to be quarterly results in late January. Nasdaq’s earnings page lists January 29 as an estimated report date; investors will be looking for any shift in demand signals across construction and resource end markets, and for management’s tone on pricing and dealer inventories.

Stock Market Today

  • Johnson Controls International (JCI) Valuation Review Amid Recent Share Decline
    June 11, 2026, 10:52 AM EDT. Johnson Controls International (NYSE:JCI) shares fell 5.7% recently, despite solid annual revenue of US$24.4 billion and net income of US$2 billion. The stock trades slightly above its fair value estimate of US$138.11, which factors in a 9.38% discount rate and modest revenue growth forecast of 5.56%. Analyst models reflect steadier revenue expansion and improved profit margins, yet caution remains due to potential operational disruptions from a new segment structure and execution risks related to cost-saving initiatives. Investors are urged to evaluate both risks and rewards amid the short-term price weakness and maintain a close watch on ongoing financial performance and strategic execution.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
AMD stock today: Shares tick higher after hours as year-end tech selling weighs on chipmakers
Previous Story

AMD stock today: Shares tick higher after hours as year-end tech selling weighs on chipmakers

Nvidia stock dips after AI21 Labs talk report as NVDA investors size up Intel stake
Next Story

Nvidia stock dips after AI21 Labs talk report as NVDA investors size up Intel stake

Go toTop